Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Affimed Ord Shs (NQ: AFMD )

2.810 +0.040 (+1.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 448,288
Open 2.790
Bid (Size) 2.810 (10)
Ask (Size) 2.990 (100)
Prev. Close 2.770
Today's Range 2.730 - 2.860
52wk Range 2.230 - 7.390
Shares Outstanding 123,419,772
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 84 companies set new 52-week lows. 
Via Benzinga
Affimed: Q1 Earnings Insights
Affimed (NASDAQ:AFMD) reported its Q1 earnings results on Wednesday, June 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga

Performance

YTD
-50.27%
-50.27%
1 Month
-9.35%
-9.35%
3 Month
-42.18%
-42.18%
6 Month
-50.27%
-50.27%
1 Year
-60.25%
-60.25%

More News

Read More
Earnings Scheduled For June 1, 2022
Via Benzinga
Recap: Affimed Q4 Earnings
Via Benzinga
Earnings Preview: Affimed
Via Benzinga
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
Via Benzinga
Affimed Touts Encouraging Patient Responses For Its NK Cell Therapy In Lymphoma Settings
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Recap: Affimed Q3 Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022
Via Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Via Benzinga
Earnings Scheduled For March 31, 2022
Via Benzinga
Earnings Outlook For Affimed
Via Benzinga
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
Via Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Via Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
3 Best Biopharma Stocks to Buy During This Industrywide Fire Sale
Via The Motley Fool
Exposures COVID-19
Affimed's Lymphoma Candidate Shows 100% Objective Response Rate At Highest Dose
Via Benzinga
Why Affimed Stock Is On Fire Today
Via The Motley Fool
Why Affirmed Stock Was Up More Than 12% Wednesday
Via The Motley Fool
Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Affimed NV (AFMD) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2021
Via Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Via Benzinga
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.